Home ChanTest

ChanTest

acquired
-
A Biotechnology Company

Basic Information

ChanTest has developed the world's most comprehensive library of validated human ion channel-expressing cell lines to meet all ion channel needs for its pharmaceutical and biotechnology clients. Services range from early functional screening of drug candidates or profiling during the drug discovery process, to a full suite of in vitro GLP service products for cardiac risk assessment. ChanTest collaborates with clients to accelerate the drug development process, saving time and money, and ultimately – helping to create better and safer drugs.
ChanTest
--
51~100 people
January 01, 1998
info@chantest.com